StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Agenus's EV/EBITDA was 7.4× on Nov 10, 2026.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20267.4×–

More Agenus figures

See a number that looks wrong?